The Claim
Fluvastatin reduces left ventricular mass index by approximately 18 units (from 100±23 to 82±15 g/m²) in hypertensive patients over 12 months, independent of lipid changes.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In patients with high blood pressure, taking fluvastatin for 12 months results in a measurable decrease in heart muscle thickness, even when cholesterol levels do not change.
See the scientific wording
Fluvastatin reduces left ventricular mass index by approximately 18 units (from 100±23 to 82±15 g/m²) in hypertensive patients over 12 months, independent of lipid changes, suggesting a direct effect on cardiac remodeling.
Fluvastatin blocks a cellular signal that makes heart muscle cells grow larger, causing the heart wall to thin without changing cholesterol levels.
What the research says
1 studyStudy: Effects of fluvastatin on insulin resistance and cardiac morphology in hypertensive patients
This study found that a cholesterol-lowering drug called fluvastatin made the heart muscle thinner in people with high blood pressure—even when their cholesterol didn’t change. That means the drug might be helping the heart directly, not just by lowering cholesterol.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.